home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

935 rows where filing_year = 2014 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • first_quarter 235
  • third_quarter 235
  • fourth_quarter 233
  • second_quarter 232

issue_code 1

  • PHA · 935 ✖

filing_year 1

  • 2014 · 935 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1511586 RED+BLUE STRATEGIES 95894dfb-5688-4159-9bf7-419d9d6e2581 Q1 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2014 first_quarter PHA Issues related to opioid abuse interventions and policies to help curb fraud and abuse, while at the same time improving outcomes for individuals with pain management needs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-03T11:35:28.473000-04:00
1511597 AMERICAN COLLEGE OF CLINICAL PHARMACY 390e2540-aa5c-4892-a626-81dd69025cd7 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2014 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   145515 0 0 2014-04-03T12:13:31.350000-04:00
1511638 KATE MOSS b0ee7495-59ce-4325-bd4e-93e4714761cc Q1 KATE MOSS 25988 CVS HEALTH 2014 first_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-04-03T13:47:57.277000-04:00
1511933 HEARTLAND SOLUTIONS GROUP, INC. d9b8bbe7-626b-4657-a790-b31ece02f760 Q1 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2014 first_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2014-04-06T16:15:18.437000-04:00
1511938 INJURED WORKERS PHARMACY f5d37e16-6ca6-4ac6-8575-a85abf6f612c Q1 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2014 first_quarter PHA n/a HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-04-07T08:56:20.080000-04:00
1511949 CYBER SECURITY RESEARCH CONSULTANTS, LLC e4648362-3f9e-4837-9557-9811f348aad3 Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2014 first_quarter PHA Monitoring Drug importation legislation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-07T10:23:26.183000-04:00
1512048 RED+BLUE STRATEGIES fdb0d803-144c-499d-8965-66ae5cd44e25 Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2014 first_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy.Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-07T15:19:16.450000-04:00
1512856 RED+BLUE STRATEGIES 71dbeabf-e0e1-4bcd-b73c-1f2e065da3bd Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2014 first_quarter PHA H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negative impact peoples access to prescription medications through mail. Issues related to the practice of giving coupons for certain prescription medications.CMS call letter focused on changes in policies regarding mail order and pharmacy networks. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-09T11:11:35.240000-04:00
1513046 MR. VINCENT A. PANVINI 86d82cbe-8f69-434d-82ad-9b6be3e0f65d Q1 MR. VINCENT A. PANVINI 401008845 PHRMA 2014 first_quarter PHA TRANSPACIFIC PARTNERSHIP, MEDICARE PART D HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-04-09T14:14:30.177000-04:00
1513072 MR. VINCENT A. PANVINI f0d1adc1-67b9-4659-b970-227fe279c007 Q1 MR. VINCENT A. PANVINI 401008845 ELI LILLY AND COMPANY 2014 first_quarter PHA TransPacific Partnership, Medicare Part D Rebates HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-04-09T14:24:39.167000-04:00
1513270 THORSEN FRENCH ADVOCACY LLC fdb93c96-9c46-4661-a789-08333b0a540c Q1 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2014 first_quarter PHA Issues related to access to pharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-10T09:48:45.607000-04:00
1513318 UNIVERSITY OF IOWA db2378b5-fba9-49a5-b463-d076a3461aee Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2014 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   85562 0 0 2014-04-10T10:24:07.750000-04:00
1513339 RED+BLUE STRATEGIES eba8803a-6509-4ac6-b84e-053ed14c950b Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2014 first_quarter PHA Issues related to continuing to increase the supply of new and innovative antibiotics that will help to treat the myriad antibiotic resistant strains of bugs like MRSA. H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act - focused on reinvigorating the pipeline for new antibiotics. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-10T10:25:08.967000-04:00
1513402 THE MATHIS HARPLE GROUP 31e180be-dcf3-4618-b226-8fc959cad1ce Q1 THE MATHIS HARPLE GROUP 322911 PILMA 2014 first_quarter PHA Medicare Pt D rebates, TransPacific Partnership HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-10T11:51:24.510000-04:00
1513521 ABRAHAM & ROETZEL, LLC 224c0c22-f425-4ff1-bed9-d9bc7ee5adc1 Q1 ABRAHAM & ROETZEL, LLC 400954757 MATCHRX 2014 first_quarter PHA Drug Quality and Security Act. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-10T13:53:26.870000-04:00
1513683 STANTON PARK GROUP 0b0d504b-8b10-4e30-9e2c-3d98a1cc934f 1T STANTON PARK GROUP 83717 ALKERMES, INC. 2014 first_quarter PHA increasing acceptance of medication assisted therapy in treating abuse of alcohol and opioid dependence HOUSE OF REPRESENTATIVES,SENATE     0 1 2014-04-10T16:18:34.387000-04:00
1513898 THE WALTER GROUP ead87b6a-7f1e-4a37-a0e3-f957680d972c Q1 THE WALTER GROUP 309537 AMERISOURCEBERGEN 2014 first_quarter PHA H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R. 1919, H.R. 3204, S. 957 & S. 959, Pharmaceutical pedigree anti-counterfeiting legislation and provisions affecting pharmaceutical compounding. Legislation pertaining to drug manufacturing shortages. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-11T10:19:00.867000-04:00
1514185 ANIMAL HEALTH INSTITUTE 5d1c9c26-7cb6-45c2-9960-8891dcdf4271 Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2014 first_quarter PHA Issues related to illegal drug manufacturing under the guise of compounding. HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)   30000 0 0 2014-04-11T13:54:34.147000-04:00
1514241 INDEPENDENT PHARMACY COOPERATIVE 7e230d40-51ab-4373-9088-00a0362a791a Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2014 first_quarter PHA CMS Proposed Program Changes for Medicare Advantage and Prescription Drug Benefit Program for Conract Year 2015-Support Changes to Preferred Networks, Mail Order Prescriptions and MTM Services. Centers For Medicare and Medicaid Services (CMS),SENATE     0 0 2014-04-11T14:15:50.657000-04:00
1514364 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 019d33fd-0de1-4d32-a042-1ec651d7b263 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2014 first_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2014-04-11T15:47:44.800000-04:00
1514383 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fcc30e29-5c19-4ede-bb88-98d6ad938fba Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2014 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 460 - Patients Access to Treatment Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2014-04-11T16:05:51.060000-04:00
1514388 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c1948a21-faeb-424a-8c7b-8039e6df1609 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2014 first_quarter PHA ssues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-11T16:06:51.683000-04:00
1515170 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 22d648d9-7019-4806-b1c5-d463cfd8b533 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2014 first_quarter PHA Issues related to drug shortages. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2014-04-14T14:13:35.250000-04:00
1515520 RUBICON ADVISORS, LLC 6b683605-c1f0-4b30-aa3c-98826c7465a5 Q1 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2014 first_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2014-04-14T15:29:30.937000-04:00
1515531 RUBICON ADVISORS, LLC 81ba914d-aecb-44f8-9443-d0ca7d55572b Q1 RUBICON ADVISORS, LLC 315091 DYNAVAX TECHNOLOGIES 2014 first_quarter PHA Food and Drug Administration - Vaccines Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-14T15:37:35.653000-04:00
1515567 RUBICON ADVISORS, LLC 20387932-f5b1-4b2f-bc33-0ba2c2de9642 Q1 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2014 first_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-14T15:48:44.437000-04:00
1515570 RUBICON ADVISORS, LLC bdd4779c-f2cd-42ab-a7ca-48e82c7b35b8 Q1 RUBICON ADVISORS, LLC 315091 ALLIANCE TO PREVENT THE ABUSE OF MEDICINES 2014 first_quarter PHA Prescription Drug Abuse Police HOUSE OF REPRESENTATIVES,SENATE 52500   0 0 2014-04-14T15:52:46.030000-04:00
1515619 TAUZIN CONSULTANTS, LLC 9b830f4e-80fd-4774-950f-b09b6759e074 Q1 TAUZIN CONSULTANTS, LLC 400671007 PILLGUARD MEDICATION DELIVERY SYSTEMS 2014 first_quarter PHA Building awareness of and support for the PillGuard Medication Delivery System as a tool for medication adherence and prescription drug abuse prevention. HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2014-04-14T16:07:18-04:00
1515812 CHAMBER HILL STRATEGIES 93eadd56-2bd5-49bc-a4c0-f9f5063f0c6c Q1 CHAMBER HILL STRATEGIES 400645947 AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) 2014 first_quarter PHA Implementation issues related to P.L. 113-54, the Drug Quality and Security Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-04-14T17:31:57.123000-04:00
1515847 VENABLE LLP f07a4467-26aa-4dd8-9654-5da12c3c8ebb Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2014 first_quarter PHA Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-14T18:23:07.950000-04:00
1515885 DELAHUNT GROUP, LLC 2b395064-06f3-4fc7-a4f8-42411e51bb57 Q1 DELAHUNT GROUP, LLC 401066001 HEALIANCE PHARMACEUTICALS 2014 first_quarter PHA innovative diabetes treatment. HOUSE OF REPRESENTATIVES,Natl Security Agency (NSA),SENATE,State, Dept of (DOS),Treasury, Dept of 45000   0 0 2014-04-14T23:57:17.060000-04:00
1516079 BROWN RUDNICK LLP b1df4802-0b58-47d1-9bda-57a3f63e82e7 Q1 BROWN RUDNICK LLP 287895 APOTEX CORPORATION 2014 first_quarter PHA Issues relating to Risk Evaluation and Mitigation Strategies; Drug Quality and Security Act ( P.L. 113-54); FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (RIN:0910-AG94). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-04-15T10:31:23.683000-04:00
1516130 ROCK & ASSOCIATES f792ec5c-3008-4018-9825-0f7345870290 Q1 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T10:37:36.823000-04:00
1516161 BROWN RUDNICK LLP 914bbe5c-9746-47d6-80a9-0051b9002b45 Q1 BROWN RUDNICK LLP 287895 PRIME THERAPEUTICS 2014 first_quarter PHA Issues relating to generic pharmaceutical utilization Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-15T10:44:50.013000-04:00
1516227 ROCK & ASSOCIATES e05c688a-7a08-4d87-ace6-556c5e873971 Q1 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-04-15T10:53:13.137000-04:00
1516271 ROCK & ASSOCIATES e780d2dc-8928-4b78-9932-eebddd2eab9a Q1 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T11:03:32.543000-04:00
1516312 ROCK & ASSOCIATES 3d0a8656-b467-4d87-8bda-b1c18be6c83d Q1 ROCK & ASSOCIATES 33545 US COMPOUNDING 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T11:15:45.903000-04:00
1516330 ROCK & ASSOCIATES e9d0d74f-0cf2-4cdb-bb93-bd97404f0ddd Q1 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T11:25:53.823000-04:00
1516341 THE PROCTER AND GAMBLE COMPANY b49cbf2b-171c-4eac-8bdf-803d6c1eb90f Q1 THE PROCTER AND GAMBLE COMPANY 32225 THE PROCTER AND GAMBLE COMPANY 2014 first_quarter PHA Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013; HR 3969, Preventing Abuse of Cough Treatments Act of 2013; S.2141, The Sunscreen Innovation Act; HR 4250, The Sunscreen Innovation Act Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR)   1094205 0 0 2014-04-15T11:29:57.590000-04:00
1516374 ROCK & ASSOCIATES 61fcb1d6-4b11-4270-81b7-de821ca4138b Q1 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T11:34:04.230000-04:00
1516421 ROCK & ASSOCIATES 4915c8e5-15d7-4372-9e96-4d8082ff7458 Q1 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2014 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2014-04-15T11:43:17.013000-04:00
1516930 CAPITOL COUNSEL LLC ca65e24d-7ab4-43ae-86f4-327538e21806 Q1 CAPITOL COUNSEL LLC 313715 AMERICAN HEALTH CARE ASSOCIATION 2014 first_quarter PHA S.1560: Nursing Home Resident Pain Relief Act of 2011. S.3604: Improving Dementia Care Treatment for Older Adults Act of 2012. S.621: Safe Prescribing Act. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2014-04-15T14:59:57.683000-04:00
1516974 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 02b5f36e-0482-415e-a135-73f18cfecf19 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2014 first_quarter PHA Fairness for Small Pharmacies in Part D Preferred Networks; Lifting Prohibition for Home Delivery of Diabetes Testing Supplies Home Delivery (H.R. 2845/S. 1935) ; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013;H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursement Cuts; PBM audit and generic pricing transparency and pricing reform; S. 867 - Medicare Prescription Drug Program Integrity and Transparency Act of 2013; CMS proposed rule on Medicare Part D; H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013; H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   420000 0 0 2014-04-15T15:14:06.387000-04:00
1517186 PARRY, ROMANI, DECONCINI & SYMMS 0ae2543b-f3cd-4988-957e-f86630d8a7de Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2014 first_quarter PHA Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2014-04-15T16:16:55.450000-04:00
1517239 CAPITOL HILL CONSULTING GROUP ffbaeccc-b50a-440c-9f22-f60443745712 Q1 CAPITOL HILL CONSULTING GROUP 72053 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2014 first_quarter PHA Pharmaceutical Compounding and Accountability Act (S. 959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2014-04-15T16:35:12.560000-04:00
1517262 CAPITOL HILL CONSULTING GROUP 3bd6e2d3-356f-4804-8230-4e1a90163574 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2014 first_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-04-15T16:44:22.467000-04:00
1517297 CAPITOL HILL CONSULTING GROUP e4cb23fb-a0a2-4e30-8dec-d1eef651fa62 Q1 CAPITOL HILL CONSULTING GROUP 72053 WELLNESS PHARMACY 2014 first_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues related to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-15T16:54:33.480000-04:00
1517320 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 712ff2d4-64d7-41a6-8662-dc2e29b92997 Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2014 first_quarter PHA PseudoephedrinePseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Potential legislation to grant additional authority to the Drug Enforcement Administration (DEA) to grant exemptions to the provisions of the Combat Methamphetamine Epidemic Act of 2005 (P.L. 109-177); no bill number. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE     0 0 2014-04-15T17:00:37.513000-04:00
1517405 FLYNN & ASSOCIATES, INC. 0589e0e6-0c8c-41d7-b40f-a430c952a4ab Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2014 first_quarter PHA Medicare Part-D rebates HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-04-15T18:24:01.230000-04:00
1517420 OREGON HEALTH & SCIENCE UNIVERSITY 8f902d1b-474f-48ea-8d33-9d8c996e666f Q1 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2014 first_quarter PHA 340b Drug Discount Program for safety net hospitals Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2014-04-15T19:35:05.380000-04:00
1517941 CAPITOL HILL CONSULTING GROUP e487685a-b0fe-426d-ac66-2158a50b8449 Q1 CAPITOL HILL CONSULTING GROUP 72053 ROCK & ASSOCIATES 2014 first_quarter PHA Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204) Issues relating to implementation of the Compounding Quality Act HOUSE OF REPRESENTATIVES,SENATE 28000   0 0 2014-04-16T10:08:13.337000-04:00
1517979 MASON CONSULTING, LLC 038c1c3c-8334-46a5-aabf-e7f324a51849 Q1 MASON CONSULTING, LLC 400660986 NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS 2014 first_quarter PHA Legislation and policies relating to: FDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding Americas Pharmaceuticals Act S. 621 - Safe Prescribing Act S. 959 - Pharmaceutical Compounding Quality and Accountability Act H.R. 3089 - Compounding Clarity Act H.R. 3204 - Drug Quality and Security Act (Public Law 113-54) H.R 4069 - Ensuring Patient Access and Effective Drug Enforcement Act Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office 23450   0 0 2014-04-16T10:14:16.507000-04:00
1518039 GREATER NEW YORK HOSPITAL ASSOCIATION 4d86fe47-7c0d-42f7-963f-f71a81512cf9 Q1 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2014 first_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance and regulatory risk-based framework (FDA-2011-D-0530 andFDA-2014-N-0339); regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); ongoing pharmaceutical issues pertaining to drug shortages and significant price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); maximum allowable cost price transparency (CMS-4159-P). Centers For Medicare and Medicaid Services (CMS),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),SENATE,White House Office   260000 0 0 2014-04-16T10:27:44.477000-04:00
1518327 THE INGRAM GROUP LLC 5ac03f94-b749-4e13-885a-57d928c07195 Q1 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2014 first_quarter PHA Issues related to pharmaceutical importation. Issues related to generic drugs. Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act, P.L. 113-54. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-16T11:26:13.193000-04:00
1518386 KOUNTOUPES DENHAM CARR & REID, LLC 9cfda2f4-d76c-4641-a6e1-4efcee7fa383 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2014 first_quarter PHA General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic track- ing system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues relating to budget sequestration and the impact of the medical device user fee program, including H.R.2725, FDA Safety over Sequestration Act of 2013and S.1413, FDA User Fee Protection Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-04-16T11:38:32.930000-04:00
1518496 BLUECROSS BLUESHIELD OF TENNESSEE 4b35d439-ba25-480d-b321-bf61b65a7fa8 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2014 first_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2014-04-16T12:09:07.337000-04:00
1518706 BUCHANAN INGERSOLL & ROONEY PC 4c6fb45f-cf7c-4e05-83de-cf029bd0bf5d Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO 2014 first_quarter PHA Life sciences, orphan drugs, medical devices, budget HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-16T12:51:51.720000-04:00
1519102 NOVO NORDISK INC. 93fba3cf-47d7-4313-a838-136da7c3e7fe Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2014 first_quarter PHA HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA)   710000 0 0 2014-04-16T14:21:00.957000-04:00
1519209 BROWN RUDNICK LLP 2419d881-784a-4aca-b5c3-9d6ce269b8cb Q1 BROWN RUDNICK LLP 287895 AMNEAL PHARMACEUTICALS 2014 first_quarter PHA Issues related to FDA rule on drug labeling; issues relating to Risk Evaluation and Mitigation Strategies; Drug Quality and Security Act ( P.L. 113-54); FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (RIN:0910-AG94). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-16T14:34:31.833000-04:00
1519305 BROWN RUDNICK LLP d8433718-f870-492c-8488-2f9f95fee107 Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2014 first_quarter PHA H.R. 4069-Ensuring Patient Access and Effective Drug Enforcement Act"; Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II [NPRM Docket No. DEA-389] HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-16T14:47:57.333000-04:00
1519438 SCONSET STRATEGIES, LLC 755365d7-b057-4d38-ada3-fb4dc7dd832c Q1 SCONSET STRATEGIES, LLC 400794388 FREEMAN ALLERGY, INC. 2014 first_quarter PHA Meetings regarding securing clinical trials at Johns Hopkins University. Meetings regarding securing clinical trials at The Redstone Arsenal- Huntsville, Alabama. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-16T15:00:35.317000-04:00
1519450 BROWN RUDNICK LLP 37e37ac0-b2bb-4b9f-a2c1-ccfbb667b646 Q1 BROWN RUDNICK LLP 287895 HOSPIRA, INC. 2014 first_quarter PHA Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products) HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2014-04-16T15:01:39.020000-04:00
1519729 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 548a22fa-5ec7-4d09-ae38-741293d73c05 1A CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2014 first_quarter PHA Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC SwitchSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. HOUSE OF REPRESENTATIVES,SENATE   320000 0 0 2014-04-16T15:48:05.943000-04:00
1519943 MR. GALEN RESER 8838a224-4e16-4376-a01d-98c8467e661a Q1 MR. GALEN RESER 401055978 PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) 2014 first_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, H.R. 2835, "Restoring Access to Medication Act of 2013." FDA's proposed changes to generic drug labeling. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-16T16:22:52.473000-04:00
1520189 ACADEMY OF MANAGED CARE PHARMACY c6dbf213-efd7-44a5-8e95-da826391577e Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2014 first_quarter PHA Biosimilar naming--supporting Congressional action to seek FDA decision on biosimilar naming Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   199000 0 0 2014-04-16T17:31:11.257000-04:00
1520203 EVERGREEN ASSOCIATES, LTD. 55252caf-20fc-4391-9183-0ab3996ad289 Q1 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2014 first_quarter PHA - RIN: 0910-AG18, Electronic Distribution of Content Labeling for Human Prescription Drug and Biological Products - Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts - S. 752/H.R. 1608: Cody Miller Initiative for Safer Prescriptions Act - Department of Agriculture Appropriations Act, 2015 Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA) 10000   0 0 2014-04-16T17:33:15.303000-04:00
1520754 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 2f5d8c99-9ab8-41f0-82c6-c191abb233cd Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2014 first_quarter PHA Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   267000 0 0 2014-04-17T09:11:50.767000-04:00
1520802 THE D MAJOR GROUP 71199576-299b-4448-9a27-751ca8c3f213 Q1 THE D MAJOR GROUP 401103162 ALLERGAN INC (FORMERLY ACTAVIS INC ) 2014 first_quarter PHA H.R. 3204, The Drug Quality and Security Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-04-17T09:30:00.753000-04:00
1520821 APOTEX CORP. df106649-58e7-48fb-a6a6-f46f8ec2f561 Q1 APOTEX CORP. 310973 APOTEX CORP. 2014 first_quarter PHA Federal policy regarding Public Law 113-54, the Drug Quality and Security Act, Title II, Drug Supply Chain Security, Section 581, Definitions, provision relating to the definition of manufacturer;Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing; FDA proposed rule,Supplemental Applications Proposing Labeling Changes For Approved Drugs And Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including Biological Products," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   130000 0 0 2014-04-17T09:36:05.783000-04:00
1520847 THE D MAJOR GROUP d92092b5-5adb-4ca0-b4b2-bc89d913e028 Q1 THE D MAJOR GROUP 401103162 HEALTH CARE SUPPLY CHAIN ASSOCIATION 2014 first_quarter PHA H.R. 3204, The Drug Quality and Security Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-17T09:48:15.377000-04:00
1520981 THE D MAJOR GROUP 6ab5ac8c-b032-4003-b6f3-a1a99e80cf8b Q1 THE D MAJOR GROUP 401103162 CVS CAREMARK 2014 first_quarter PHA H.R. 3204, The Drug Quality and Security Act H.R. 3392, The Medicare Part D Patient Safety & Drug Abuse Prevention Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-17T10:06:48.067000-04:00
1521170 MCDERMOTT WILL & SCHULTE LLP b1a3f5bb-6719-48a7-8792-f6adb1578611 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2014 first_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE     0 0 2014-04-17T10:33:45.783000-04:00
1521624 NATIONAL PATIENT ADVOCATE FOUNDATION 321a7781-2d5b-4b00-9337-12c7d2ea6d5f Q1 NATIONAL PATIENT ADVOCATE FOUNDATION 28311 NATIONAL PATIENT ADVOCATE FOUNDATION 2014 first_quarter PHA Specialty Tiers, Biosimilars, Innovation HOUSE OF REPRESENTATIVES,SENATE   33873 0 0 2014-04-17T11:20:10.017000-04:00
1521755 CROSSROADS STRATEGIES, LLC e2227ff2-2ca4-49f5-b9c3-383cf380a92f Q1 CROSSROADS STRATEGIES, LLC 400531586 LUMARA HEALTH 2014 first_quarter PHA Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2014-04-17T11:32:45.800000-04:00
1522244 FTI GOVERNMENT AFFAIRS c9d17ba7-655e-4b8c-86f4-40a566c8b770 Q1 FTI GOVERNMENT AFFAIRS 401054971 AMERICAS HEALTH INSURANCE PLANS (AHIP) 2014 first_quarter PHA H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs; H.R. 3204, Drug Quality and Security Act (Upton) - drug safety issues; S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-17T12:56:34.300000-04:00
1522795 THORN RUN PARTNERS 59452f01-ad4f-4706-8844-ffb23ddba699 Q1 THORN RUN PARTNERS 400534596 INSPIRION PHARMACEUTICALS, LLC 2014 first_quarter PHA Issues related to promoting innovation in abuse-deterrent opioids. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-17T14:14:32.003000-04:00
1522955 STANTON PARK GROUP 6f0e1c33-eb2c-4664-9bfe-75980c5e04b4 Q1 STANTON PARK GROUP 83717 MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY) 2014 first_quarter PHA Pharmacy issues, prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion. H.R. 1919 "Safeguarding America's Pharmaceuticals Act of 2013". S. 957 "Drug Supply Chain Security Act". S. 959 "Pharmaceutical Quality, Security and Accountability Act" HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2014-04-17T14:29:26.877000-04:00
1523012 KOUNTOUPES DENHAM CARR & REID, LLC b071f645-2bc2-4d19-a46d-ba6967b41788 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2014 first_quarter PHA Policy matters related to generic pharmaceuticals and biosimilars including naming, labeling, e-labeling, access and interchangeability. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 50000   0 0 2014-04-17T14:34:42.957000-04:00
1523086 SANOFI US SERVICES INC. ae211df0-4818-46dd-bfa0-e3a953a3f109 Q1 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2014 first_quarter PHA General issues related to the 340B Federal Drug Pricing Program HOUSE OF REPRESENTATIVES,SENATE   1570000 0 0 2014-04-17T14:42:07.817000-04:00
1523189 HANCE SCARBOROUGH b28359b6-725d-45e9-876b-a67c3fde13a0 Q1 HANCE SCARBOROUGH 17443 ALLIANCE OF INDEPENDENT PHARMACISTS - TEXAS 2014 first_quarter PHA Federal legislation affecting the practice of pharmacy, and FDA and DEA regulations of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2014-04-17T14:50:38.893000-04:00
1523226 PD FRAZER CONSULTING, INC. c3300eba-8817-43aa-a795-63b205ac0716 Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2014 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2014-04-17T14:53:51.987000-04:00
1523501 EMPIRE CONSULTING GROUP da2588c2-0647-41ab-9fec-1f9da1ed02d9 Q1 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2014 first_quarter PHA Issues relating to the Medicare Prescription Drug Act; H.R. 4160, Keep the Promise to Seniors Act of 2014; Budgetary issues pertaining to Medicare Part D; CMS rulemaking alterations to Medicare Part D. HOUSE OF REPRESENTATIVES 40000   0 0 2014-04-17T15:19:19.910000-04:00
1523708 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION bc50f9eb-22d8-4c69-9b6f-9c5be8bd0edb Q1 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2014 first_quarter PHA Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio).Regulatory and proposed legislative changes to Medicare part D including pharmacy networks, classes of clinical concern, mail-service pharmacy, EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors. Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs. Regulatory Implementation of the HITECH Act. FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of approval pathway for generic biologic drugs, 340B program. Issues related to the compounding of certain drugs. S. 77, Prescription Drug and Health Improvement Act S. 557, Medication Therapy Management Empowerment Act H.R. 460, Patients Access to Treatments Act H.R. 1188, Preserving Our Hometown Independent Pharmacies Act H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 1024, Medication Therapy Management Empowerment Act S.867, Medicare Prescription Drug Program Integrity and Transparency Act H.R. 2960, Medicare Prescription Drug Integrity Act of 2013 H.R. 4160, Keep the Promise to Seniors Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   939936 0 0 2014-04-17T15:45:23.377000-04:00
1523960 UNIVERSITY OF CONNECTICUT 920efb9b-191b-4e3a-8e04-d4c34185b89d Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2014 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2015, Monitor FDA salaries and expense issues; and extramural research. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2014-04-17T16:05:51.180000-04:00
1524027 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 15e52d8d-bf89-4aa9-82d2-c271f1b2954a Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2014 first_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning HRSA oversight of 340B drug discount program. Communication with the GAO on compounding. Contact concerning the Drug Quality and Security Act, H.R. 3204, all titles. Communication with the FDA on labeling of generic medications and drugs containing salts. Communication with FTCon biosimilars. Support for H.R. 3742, all titles, theAntibiotic Development to Advance patient Treatment Act. Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2014-04-17T16:11:07.660000-04:00
1524216 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 67405579-7879-4860-8fff-8c98b5b19f7e Q1 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2014 first_quarter PHA Reduce prescription drug costs in Medicare/Medicaid HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office   680000 0 0 2014-04-17T16:26:57.493000-04:00
1524561 CAPITOL COUNSEL LLC afe628ec-9d67-4fee-9b8c-82a88caf9b52 1A CAPITOL COUNSEL LLC 313715 AMERICAN HEALTH CARE ASSOCIATION 2014 first_quarter PHA S.1560: Nursing Home Resident Pain Relief Act of 2011. S.3604: Improving Dementia Care Treatment for Older Adults Act of 2012. S.621: Safe Prescribing Act. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2014-04-17T17:08:35.713000-04:00
1524570 TARPLIN, DOWNS & YOUNG, LLC 3d6e35e9-7789-4370-a816-57e854123bb3 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2014 first_quarter PHA **see addendum pageImportation of prescription drugs (H.R. 3715) Drug Shortages (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069), Hydrocodone Rescheduling (H.R. 1285, S. 621, and NPRM Docket No. DEA-389), Dextromethorphan (S. 644) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2014-04-17T17:09:38.603000-04:00
1524578 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 16e9d554-f87a-4792-a231-d66b91f831ac Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2014 first_quarter PHA S.644, Preventing Abuse of Cough Treatments Act of 2013 S. 621, Safe Prescribing Act of 2013 H.R. 1285, Safe Prescribing Act of 2013 H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013S 959, Pharmaceutical Compounding Quality and Accountability Act S 1277, Combating Prescription Drug Abuse Act S.957, Drug Supply Chain Security Act H.R.3204 - Drug Quality and Security Act H.R. 4437 - Generic Drug Pricing Fairness Act Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   740000 0 0 2014-04-17T17:11:41.523000-04:00
1524644 GOLDEN HORIZONS fa20e643-cef4-4abc-93bc-a8706ec9fb06 Q1 GOLDEN HORIZONS 44275 GOLDEN HORIZONS 2014 first_quarter PHA Monitor and advocate regarding pharmacy issues impacting Long Term Care and Post Acute Care providers and patients. Keep the Promise to Seniors Act of 2014, H.R. 4160 Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA)   95997 0 0 2014-04-17T17:29:05.507000-04:00
1524648 EXPRESS SCRIPTS, INC. 65752350-7ffd-4bee-962d-d453df30be59 Q1 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2014 first_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit design and pricing (MAC)issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act. Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Personnel Management (OPM),SENATE,White House Office   650000 0 0 2014-04-17T17:30:06.727000-04:00
1524827 MCKENNA, LONG & ALDRIDGE 3bbae8db-f3d4-4638-b163-ed7b50b9e225 Q1 MCKENNA, LONG & ALDRIDGE 76913 PURDUE PHARMA 2014 first_quarter PHA U.S. and Canadian regulatory policies regarding prescription drug abuse. HOUSE OF REPRESENTATIVES     0 0 2014-04-17T18:17:47.837000-04:00
1525340 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 4c06b5bf-2d40-4e56-87e9-7fcb995452e0 Q1 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2014 first_quarter PHA Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204). Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   80000 0 0 2014-04-18T09:26:35.353000-04:00
1525447 WILLIAMS AND JENSEN, PLLC e919aa1c-b0bf-40f3-9596-163ea31bf305 Q1 WILLIAMS AND JENSEN, PLLC 41454 PHARMACY SERVICES 2014 first_quarter PHA Regulations of compounding pharmacies. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2014-04-18T09:43:11.727000-04:00
1525486 ELI LILLY AND COMPANY 3e3af76b-8a58-4088-bbcc-b40c057f8d65 Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2014 first_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   2086000 0 0 2014-04-18T09:46:23.477000-04:00
1525501 FORBES-TATE fe72cb6d-a012-4391-9d5d-f72f86ecc696 1T FORBES-TATE 400976792 MERCK 2014 first_quarter PHA Issues related to pharmaceutical drug safety track and trace program legislation. HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2014-04-18T09:48:26.743000-04:00
1525744 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 9dd3d0a3-82fb-441b-a838-ae1d7779c643 Q1 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 1967 AMERICAN COLLEGE OF EMERGENCY PHYSICIANS 2014 first_quarter PHA H.R.3089-Compounding Clarity Act H.R.3528-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 S.1323-Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013 HOUSE OF REPRESENTATIVES,SENATE   538612 0 0 2014-04-18T10:25:41.657000-04:00
1525764 FAEGRE BAKER DANIELS CONSULTING 93dc599d-9ac6-4f07-9818-75ee66f3c72e Q1 FAEGRE BAKER DANIELS CONSULTING 34158 PAPCC COALITION 2014 first_quarter PHA Medicare policy HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2014-04-18T10:29:44.433000-04:00
1525777 ALLERGAN USA, INC. e39c8227-c026-49d2-b5b3-138369812bbe Q1 ALLERGAN USA, INC. 63837 ALLERGAN USA, INC. 2014 first_quarter PHA Drug Labeling Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE   420000 0 0 2014-04-18T10:30:34.387000-04:00
1525860 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 64bf1251-7221-4a15-a1cc-a94bd3093e4e Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2014 first_quarter PHA Proposals relating to the regulation of direct to consumer prescription drug advertising FDA proposal relating to disclosure of side effects in television advertisements Commerce, Dept of (DOC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),Office of Science & Technology Policy (OSTP),SENATE   380000 0 0 2014-04-18T10:38:20.353000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1499.476ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API